Rocío Echarri
About
Rocío Echarri is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Epidemiology.
According to data from OpenAlex, Rocío Echarri has authored 27 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Nephrology and 4 papers in Epidemiology. Recurrent topics in Rocío Echarri's work include Blood Pressure and Hypertension Studies (12 papers), Dialysis and Renal Disease Management (6 papers) and Heart Rate Variability and Autonomic Control (4 papers). Rocío Echarri is often cited by papers focused on Blood Pressure and Hypertension Studies (12 papers), Dialysis and Renal Disease Management (6 papers) and Heart Rate Variability and Autonomic Control (4 papers). Rocío Echarri collaborates with scholars based in Spain, Germany and Argentina. Rocío Echarri's co-authors include Vivencio Barrios, Milagros Fernández Lucas, J. Ortuño, J.L. Teruel, Diego Gómez‐Coronado, Miguel A. Lasunción, H. Ortega, Alberto Dávalos, Patricia Castilla and Carlos Escobar and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and Nephrology Dialysis Transplantation.
In The Last Decade
Rocío Echarri
25 papers receiving 445 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rocío Echarri Spain | 9 | 170 | 146 | 86 | 81 | 51 | 27 | 470 | ||
| Lisa Rich Australia | 9 | 217 1.3× | 185 1.3× | 86 1.0× | 99 1.2× | 31 0.6× | 14 | 694 | ||
| James I Dower Netherlands | 8 | 81 0.5× | 226 1.5× | 100 1.2× | 119 1.5× | 24 0.5× | 9 | 536 | ||
| Javier Díez‐Espino Spain | 18 | 147 0.9× | 112 0.8× | 298 3.5× | 129 1.6× | 58 1.1× | 30 | 1.0k | ||
| Luis A. Álvarez-Sala Spain | 10 | 117 0.7× | 60 0.4× | 74 0.9× | 47 0.6× | 88 1.7× | 24 | 437 | ||
| Elba Leiva Chile | 15 | 84 0.5× | 92 0.6× | 145 1.7× | 43 0.5× | 52 1.0× | 24 | 675 | ||
| Ioana Para Romania | 8 | 68 0.4× | 98 0.7× | 81 0.9× | 29 0.4× | 39 0.8× | 28 | 515 | ||
| Milagros Fernández Lucas Spain | 10 | 44 0.3× | 148 1.0× | 67 0.8× | 59 0.7× | 115 2.3× | 67 | 586 | ||
| Laura Franzini Italy | 14 | 120 0.7× | 137 0.9× | 146 1.7× | 100 1.2× | 36 0.7× | 26 | 635 | ||
| Danijela Budimir Mršić Croatia | 11 | 55 0.3× | 132 0.9× | 36 0.4× | 25 0.3× | 31 0.6× | 37 | 474 | ||
| Arne Svilaas Norway | 11 | 103 0.6× | 89 0.6× | 85 1.0× | 77 1.0× | 156 3.1× | 28 | 648 |
Countries citing papers authored by Rocío Echarri
Since
Specialization
Citations
This map shows the geographic impact of Rocío Echarri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocío Echarri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocío Echarri more than expected).
Fields of papers citing papers by Rocío Echarri
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rocío Echarri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocío Echarri. The network helps show where Rocío Echarri may publish in the future.
Co-authorship network of co-authors of Rocío Echarri
This figure shows the co-authorship network connecting the top 25 collaborators of Rocío Echarri. A scholar is included among the top collaborators of Rocío Echarri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocío Echarri. Rocío Echarri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Belmar, Lara, Rosa Melero, Trinidad Serrano, et al.. (2024). Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: renal replacement therapy and mortality. FRA-COVID SEN Registry Data. Nefrología (English Edition). 44(4). 527–539.
2.
Belmar, Lara, Rosa Melero, María Luisa Serrano Salazar, et al.. (2023). Caracterización de la población con fracaso renal agudo durante la hospitalización por COVID-19 en España: tratamiento renal sustitutivo y mortalidad. Datos del Registro FRA-COVID SEN. SHILAP Revista de lepidopterología. 44(4). 527–539.
3.
Ortíz, Alberto, José Pórtoles, Patricia de Sequera, et al.. (2023). Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing. SHILAP Revista de lepidopterología. 9(3). 187–196.
4.
Sequera, Patricia de, Rafael Pérez-García, Manuel Molina, et al.. (2021). Advantages of the use of citrate over acetate as a stabilizer in hemodialysis fluid: A randomized ABC-treat study. Nefrología (English Edition). 42(3). 327–337.
5.
Sequera, Patricia de, Rafael Pérez-García, Manuel Molina, et al.. (2021). Ventajas del uso de citrato respecto al acetato como estabilizante en el líquido de hemodiálisis: estudio aleatorizado ABC-treat. Nefrología. 42(3). 327–337.
6.
García, Rafael Pérez, et al.. (2019). Prospective randomized multicenter study to demonstrate the benefits of haemodialysis without acetate (with citrate): ABC-treat Study. Acute effect of citrate. Nefrología (English Edition). 39(4). 424–433.
7.
Sequera, Patricia de, et al.. (2018). FP457MULTICENTER, PROSPECTIVE, RANDOMISED, CROSSOVER TRIAL TO DEMONSTRATE THE BENEFITS OF HEMODIALYSIS WITHOUT ACETATE (WITH CITRATE): ABC-TREAT STUDY. Nephrology Dialysis Transplantation. 33(suppl_1). i189–i190.
8.
Barrios, Vivencio, Carlos Escobar, Alberto Calderón, et al.. (2010). Gender differences in the diagnosis and treatment of left ventricular hypertrophy detected by different electrocardiographic criteria. Findings from the SARA study. Heart and Vessels. 25(1). 51–56.
9.
Barrios, Vivencio, et al.. (2009). Pulse Pressure and the Metabolic Syndrome in Patients With Hypertension. PubMed. 4(2). 72–75.
10.
Barrios, Vivencio, Carlos Escobar, & Rocío Echarri. (2009). Importance of medication adherence from the ONTARGET and TRANSCEND points of view. Fundamental and Clinical Pharmacology. 23(2). 259–260.
11.
Barrios, Vivencio, Carlos Escobar, Rocío Echarri, & Fernando de Álvaro. (2009). New therapeutic progress in cardiorenal protection of the hypertensive patient with a focus on olmesartan.
12.
Barrios, Vivencio, et al.. (2008). Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: A 9-month, prospective, randomized, open-label, blinded-evaluation trial. Clinical Therapeutics. 30(1). 98–107.
13.
Barrios, Vivencio, Carlos Escobar, Nekane Murga, et al.. (2008). Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice. Journal of Hypertension. 26(11). 2230–2235.
14.
Escobar, Carlos, Vivencio Barrios, Alberto Calderón, et al.. (2008). Electrocardiographic Left Ventricular Hypertrophy Regression Induced by an Angiotensin Receptor Blocker‐Based Regimen in Hypertensive Patients With the Metabolic Syndrome: Data From the SARA Study. Journal of Clinical Hypertension. 10(3). 208–214.
15.
Barrios, Vivencio, et al.. (2007). Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. Journal of Human Hypertension. 21(6). 479–485.
16.
Barrios, Vivencio, Carlos Escobar, Alberto Calderón, et al.. (2007). Blood Pressure and Lipid Goal Attainment in the Hypertensive Population in the Primary Care Setting in Spain. Journal of Clinical Hypertension. 9(5). 324–329.
17.
Castilla, Patricia, Rocío Echarri, Alberto Dávalos, et al.. (2006). Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. American Journal of Clinical Nutrition. 84(1). 252–262.
18.
Marcén, R., C. Galéano, J Pascual, et al.. (2005). Lumbar Bone Mineral Density After Kidney Transplantation: A Three-Year Prospective Study. Transplantation Proceedings. 37(3). 1466–1467.
19.
Redondo, C, et al.. (2004). [Colitis due to cytomegalovirus in a dialysis patient].. PubMed. 24(3). 279–82.
20.
Teruel, J.L., Milagros Fernández Lucas, José Luís Merino, et al.. (2004). [Ionic dialysance to control the dose of dialysis. One year experience].. PubMed. 23(5). 444–50.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lisa Rich Breakdown of academic impact, for papers by James I Dower Breakdown of academic impact, for papers by Javier Díez‐Espino Breakdown of academic impact, for papers by Luis A. Álvarez-Sala Breakdown of academic impact, for papers by Elba Leiva Breakdown of academic impact, for papers by Ioana Para Breakdown of academic impact, for papers by Milagros Fernández Lucas Breakdown of academic impact, for papers by Laura Franzini Breakdown of academic impact, for papers by Danijela Budimir Mršić Breakdown of academic impact, for papers by Arne Svilaas